A deeper dive into Cancer Epidemiology, Hypofractionared Radiotherapy trial

If you're having trouble viewing this email, you may see it online. Share this email:

Feature Story Cancer Epidemiology Program: Pan Life-Span Population Studies Beyond Odds Ratios and P-Values The fundamental unit in cancer treatment is the individual patient, but the unseen hand that informs and guides the entire continuum of cancer care--from screening to risk assessment, treatment to survivorship--is knowledge gained from analysis of patient populations... [Read More] Spotlight Trial A New Trial is Comparing Hypofractionated Radiotherapy to Conventional Radiotherapy in Women Who Have Undergone Mastectomy and Implant-Based Reconstruction  A new randomized multicenter trial led by Rinaa S. Punglia, MD, MPH (DFCI), and Julia S. Wong, MD, is comparing clinical and cosmetic outcomes in women with breast cancer... [Read More] More on Cores DNA Resource Core  In this DF/HCC eNews Spotlight Edition, we present the DF/HCC DNA Resource Core, which provides access to specialized resources such as rapid and user-friendly Sanger DNA sequencing services and plasmid...[Read More] Publications Mixtape Here is a selection of recent collaborative publications involving DF/HCC authors for your reading pleasure. Click here to browse the "Mixtape". New Faces Members Join us in welcoming the 10 individuals from our member institutions who have recently joined DF/HCC. Learn more about these scientists, their research interests, and watch the intro videos that they have recorded. Awards Congratulations to the DF/HCC faculty who have been recognized for their outstanding research contributions since our last edition of eNews! Learn more about who was honored. Recently Awarded NIH Grants The NIH continues to recognize DF/HCC as a leader in cancer research by awarding funding to a number of our research initiatives. Learn more about these funded projects. Research Highlights from Our Member Institutions Beth Israel Deaconess Medical Center Cancer Center at BIDMC Launches Immunotherapy Institute Boston Children's Hospital A Bold Strategy to Enhance CAR T-cell Therapies, Capable of Targeting DIPG and Other Tough-to-Treat Cancers Brigham and Women's Hospital  New App Developed for Young Adults Coping with Cancer Dana-Farber Cancer Institute Blood Test Shows Potential for Early Detection of Lung Cancer Harvard Medical School No Pain, All Gain Harvard T.H. Chan School of Public Health Research Dream Team to Focus on Multiple Myeloma Precursors Massachusetts General Hospital ATR Inhibition in Tumor Cells In This Issue Spotlight Trial More on Cores Publication Playlist New Faces Awards Funding Did you know? DF/HCC published a report card on Cancer in Massachusetts.   Learn more about the DF/HCC and Harvard Catalyst Joint Cancer Report Card Our Member Institutions: Beth Israel Deaconess Medical Center  Boston Children's Hospital Brigham and Women's Hospital  Dana-Farber Cancer Institute Harvard Medical School Harvard T.H. Chan School of Public Health Massachusetts General Hospital www.dfhcc.harvard.edu dfhcc@partners.org Dana-Farber/Harvard Cancer Center Central Administration 10 Brookline Place, BP339B Brookline, MA 02445

Manage your preferences | Opt out using TrueRemove® Got this as a forward? Sign up to receive our future emails. 450 Brookline Avenue Boston , MA | 02215 US This email was sent to . To continue receiving our emails, add us to your address book.

Subscribe to our email list.